Wang Xiaolei, Su Jier, Ding Jingwen, Han Song, Ma Wei, Luo Hong, Hughes Guy, Meng Zhaoyang, Yin Yi, Wang Yanling, Li Junfa
Department of Ophthalmology, Beijing Friendship Hospital; Department of Neurobiology, Beijing Institute for Brain Disorders, Capital Medical University, Beijing.
Department of Neurobiology, Beijing Institute for Brain Disorders, Capital Medical University, Beijing; Ningbo College of Health Sciences, Ningbo.
Drug Des Devel Ther. 2016 Oct 20;10:3449-3457. doi: 10.2147/DDDT.S105362. eCollection 2016.
Ocular hypertension is an important risk factor for glaucoma. The purpose of this study was to investigate the gliotoxic effects of α-aminoadipic acid (AAA) in a rat model of AOH and its underlying mechanisms.
In the rat model of acute ocular hypertension (AOH), intraocular pressure was increased to 110 mmHg for 60 minutes. Animals were divided into four groups: sham operation (Ctrl), AOH, AOH + phosphate-buffered saline (PBS), and AOH + AAA. Cell apoptosis in the ganglion cell layer was detected with the terminal deoxynucleotidyl transferase-mediated uridine 5'-triphosphate-biotin nick end labeling (TUNEL) assay, and retinal ganglion cells (RGCs) immunostained with Thy-1 were counted. Müller cell activation was detected using immunostaining with glutamine synthetase and glial fibrillary acidic protein. Tumor necrosis factor-α (TNF-α) was examined using Western blot.
In the rat model of AOH, cell apoptosis was induced in the ganglion cell layer and the number of RGCs was decreased. Müller cell gliosis in the retinas of rats was induced, and retinal protein levels of TNF-α were increased. Intravitreal treatment of AAA versus PBS control attenuated these retinal abnormalities to show protective effects in the rat model of AOH.
In the retinas of the rat model of AOH, AAA treatment attenuated retinal apoptosis in the ganglion cell layer and preserved the number of RGCs, likely through the attenuation of Müller cell gliosis and suppression of TNF-α induction. Our observations suggest that AAA might be a potential therapeutic target in glaucoma.
高眼压是青光眼的一个重要危险因素。本研究旨在探讨α-氨基己二酸(AAA)在急性高眼压(AOH)大鼠模型中的神经胶质毒性作用及其潜在机制。
在急性高眼压(AOH)大鼠模型中,将眼压升高至110 mmHg并持续60分钟。动物分为四组:假手术组(Ctrl)、AOH组、AOH + 磷酸盐缓冲盐水(PBS)组和AOH + AAA组。采用末端脱氧核苷酸转移酶介导的尿苷5'-三磷酸生物素缺口末端标记(TUNEL)法检测神经节细胞层中的细胞凋亡,并对用Thy-1免疫染色的视网膜神经节细胞(RGCs)进行计数。使用谷氨酰胺合成酶和胶质纤维酸性蛋白免疫染色检测米勒细胞的活化情况。采用蛋白质免疫印迹法检测肿瘤坏死因子-α(TNF-α)。
在AOH大鼠模型中,神经节细胞层诱导了细胞凋亡,RGCs数量减少。诱导了大鼠视网膜中的米勒细胞胶质增生,并且视网膜中TNF-α的蛋白水平升高。与PBS对照组相比,玻璃体腔内注射AAA减轻了这些视网膜异常,在AOH大鼠模型中显示出保护作用。
在AOH大鼠模型的视网膜中,AAA治疗减轻了神经节细胞层的视网膜凋亡并保留了RGCs的数量,可能是通过减轻米勒细胞胶质增生和抑制TNF-α的诱导来实现的。我们的观察结果表明,AAA可能是青光眼的一个潜在治疗靶点。